It has also been reported that silencing NUSAP1 reduces the Wnt/β-catenin signaling pathway in nasopharyngeal cancer by downregulating phosphorylation of glycogen synthase kinase 3 beta (GSK-3β), reducing cell proliferation, and reducing invasion [11]. The gene discussed is NUSAP1; the disease is nasopharyngeal carcinoma.